Delivery Order N6264520D5002-HT940622F0060

Award Date 10/1/22
Potential Completion Date 9/30/23
Potential Value $1.1M
Ultimate Awardee
Cardinal Health, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, VA 23708, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceutical products. The $738,865.37 contract covers the period from October 1, 2021, to September 30, 2022, and supports the DHA's nuclear medicine and diagnostic imaging requirements. Cardinal Health 414, LLC is a prominent supplier of specialized medical isotopes and radiopharmaceutical therapies to federal...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the delivery of radiopharmaceutical supplies. The contract, valued at $358,406.52, was awarded by the Defense Health Agency (DHA) and has an ultimate completion date of October 1, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialized pharmaceutical products...
This federal contract award is for the supply of radiopharmaceuticals to the Defense Health Agency (DHA). The $249,466.62 firm fixed-price purchase order was awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract has an ultimate completion date of September 30, 2026. Cardinal Health 414 is a well-established provider of critical medical isotopes and radiopharmaceutical products used in nuclear medicine, oncology, and...
This is a $674,542.44 firm fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, which are radioactive pharmaceutical products used in nuclear medicine for diagnostic imaging and therapeutic applications. The contract has no set-aside designation, reflecting Cardinal Health 414, LLC's status as a large, established supplier of these specialized...
This is a federal contract award from the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceuticals, which are radioactive isotopes used in medical imaging and treatment. The contract has a ceiling value of $563,789.91 and a performance period through September 30, 2026. It is structured as a delivery order, with a firm fixed-price pricing type. The contract does not have a set-aside designation,...
This federal contract award is for the delivery of radiopharmaceuticals to the Defense Health Agency (DHA). The $145,418.67 fixed-price delivery order was transferred from a previous agency to DHA and has a completion date of September 30, 2021. The prime contractor is Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. Cardinal Health 414 is a prominent supplier of radiopharmaceuticals and specialized medical products to federal healthcare agencies,...
The Defense Health Agency awarded a firm fixed price delivery order contract worth up to $250,000.00 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the provision of radiopharmaceuticals. The contract, which has no set-aside designation, will run through September 30, 2022. Cardinal Health 414 has previously held multiple indefinite delivery contracts to supply radiopharmaceuticals, radioactive isotopes, and other nuclear medicine products and services to the Department...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract, valued at $2,715,717.87, is for the supply of various radiopharmaceuticals used in nuclear medicine, oncology, and diagnostic imaging services at VA medical facilities. The delivery order is part of a larger $39.8 million multiple-award Indefinite Delivery Vehicle (IDV) contract between the VA's...
This $161,525.58 firm-fixed-price purchase order was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., by the Department of Veterans Affairs (VA) for the supply of radiopharmaceuticals. The contract has no set-aside designation and an ultimate completion date of September 30, 2025. Cardinal Health 414 is a major supplier of nuclear medicine products and services to federal healthcare agencies, including the VA, Department of Defense, and National Institutes of Health....
This federal contract award to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc., is for the supply of radiopharmaceuticals to various U.S. government health agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD), and National Institutes of Health (NIH). The award, valued at $136,249.45, is a delivery order under an Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network 20....
  • N6264520D5002
    Indefinite Delivery Contract
  • N6264520D5002-HT940622F0060
    Delivery Order

This is a firm fixed-price delivery order worth $1,116,048.58 awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceutical supplies, which are critical for nuclear medicine, oncology, and diagnostic imaging services across federal healthcare facilities. Cardinal Health 414, LLC is an established provider of specialized medical isotopes and radiopharmaceutical therapies to federal agencies, including the Department of Veterans Affairs (VA), DHA, and National Institutes of Health (NIH). This delivery order is part of Cardinal Health's broader portfolio of Indefinite Delivery Vehicle (IDV) contracts with the VA, valued up to $39.8 million, which support routine and emergency deliveries of these time-sensitive, radioactive medical products. The contract has no set-aside designation, reflecting Cardinal Health's status as a large, for-profit healthcare services provider capable of meeting complex federal requirements.

Generated 4/25/25, 9:50 AM